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 Perinatal exposure to BPA increased the incidence of uterine abnormalities in rats4
5
 The occurrence of glandular alterations[0] increased in BPA-exposed rats treated with 6
E27
8
 ERα and PR subepithelial expression decreased in BPA-exposed rats treated with E29
10
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We assessed the long-term effect of perinatal exposure to bisphenol A (BPA) on the rat41
uterus and the uterine response to estrogen (E2) replacement therapy. BPA (0.5 or 5042
μg/kg/day) was administered in the drinking water from gestational day 9 until weaning. 43
We studied the uterus of female offspring on postnatal day (PND) 90 and 360, and the 44
uterine E2 response on PND460 (PND460-E2). On PND90, BPA-exposed rats showed45
altered glandular proliferation and α-actin expression. On PND360, BPA exposure46
increased the incidence of abnormalities in the luminal and glandular epithelium. On 47
PND460-E2, the multiplicity of glands with squamous metaplasia increased in BPA5048
while the incidence of glands with daughter glands increased in BPA0.5. The expression49
of steroid receptors, p63 and IGF-I was modified in BPA-exposed rats on PND460-E2. 50
The long-lasting effects of perinatal exposure to BPA included induction of 51
abnormalities in uterine tissue and altered response to E2 replacement therapy.52
53




BPA: Bisphenol A; DES: diethylstilbestrol GD: gestational day; PND: postnatal day; 58
E2: 17-estradiol; BrdU: bromodeoxyuridine; -SMA: smooth muscle -actin; CK: 59
cytokeratin; ER: estrogen receptor alpha; ER: estrogen receptor beta; PR: 60
progesterone receptor; IOD: integrated optical density; CT: cycle threshold; IGF-I: 61
Insulin-like growth factor-I; IGF-IR: Insulin-like growth factor-I receptor62
63














Hormonal perturbation during fetal or neonatal development may predispose individuals 65
to disease and/or dysfunction later in life [1-3]. Complete development of the rodent 66
female reproductive tract occurs during the first two weeks of postnatal life [4, 5].67
Along this period, the hormonal milieu is crucial for the correct organization and 68
differentiation of the female reproductive tract, which occurs following a complex series 69
of interactions between classical hormone receptors and signaling molecules that 70
program target cells to respond appropriately to hormonal cues later in life [4, 5].71
72
During the differentiation of the rodent female reproductive tract, the columnar (uterine) 73
and squamous (cervicovaginal) epithelia express specific molecules such as p63 that are74
necessary to determine the type of epithelium [6]. TP63 is a p53-related gene that 75
contains two alternative promoters, which give rise to transcripts that encode proteins 76
with (TAp63) or without (Np63) an amino-transactivating domain [7]. p63 is 77
commonly expressed in cervical and vaginal cells but not in the uterine epithelium [5, 78
6]. However, it has been observed that developmental exposure to xenoestrogens can 79
disturb the normal p63 expression pattern and proper uterine cytodifferentiation [8-10]. 80
81
In the adult, the processes of uterine functional differentiation are also dependent on 82
reciprocal stromal-epithelial interactions which are governed by sex steroids. For 83
example, the mitogenic effects of E2 on the uterine epithelium are mediated indirectly 84
through E2 binding to ERα in the stroma [11], which leads to epithelial proliferation 85
through an unknown mechanism, probably involving paracrine effects of stromal 86
growth factors. Since insulin-like growth factor-I (IGF-I) is produced predominantly in 87












the stroma and its receptor (IGF-IR) is mainly located in the uterine epithelium, it has 88
been suggested that IGF-I could be a critical mediator of estrogen-induced stromal-89
epithelial interactions [12].90
91
BPA is a prototypical endocrine disrupter, produced in large quantities for use in the 92
manufacture of polycarbonate plastics and epoxy resins. The lowest observed adverse93
effects level (LOAEL) for BPA established by the United States Environmental 94
Protection Agency (US EPA) is 50 mg/kg-d [13]. The established LOAEL was divided 95
by an uncertainty factor of 1000 to provide a safety margin below the LOAEL for the 96
permitted daily exposure limits. Therefore, the first safety standard set by the EPA and 97
adapted by the FDA as a reference dose for BPA was calculated to be 50 μg/kg-d. This 98
reference dose remains the current safety standard for BPA [14, 15]. Today, there are99
more than a hundred of studies showing sufficient evidence for low dose effects of BPA100
on estrogen sensitive organs[0] [1, 16-22].101
102
Developmental exposure to xenoestrogen compounds, such as BPA, affects the uterine 103
histology and uterine response to estradiol (E2) and progesterone in adulthood [23, 24]. 104
The abnormal expression of steroid-sensitive genes would lead to a dysregulation of the 105
hormonal signaling pathway.106
107
Although there is abundant evidence about the long-term effects of BPA exposure in 108
laboratory rodents, no studies have evaluated the additional effects of an estrogen 109
treatment that mimics the replacement therapy used in menopausal women [25]. In the 110
present work, we investigated the long-term effects of perinatal (gestation + lactation) 111
BPA exposure on the uterus of cycling rats and ovariectomized (OVX) adult rats treated 112












with E2. BPA was administered by the oral route, the most relevant route of exposure to113
this chemical in the general population [26, 27]. 114
115
2. MATERIALS AND METHODS 116
117
2.1 Animals.118
The experimental protocols were designed in accordance with the Guide for the Care 119
and Use of Laboratory Animals issued by the U.S. National Academy of Sciences and 120
approved by the ethics committee of the School of Biochemistry and Biological 121
Sciences, Universidad Nacional del Litoral (Santa Fe, Argentina). Rats of a Wistar-122
derived strain bred at the Department of Human Physiology (School of Biochemistry 123
and Biological Sciences, Universidad Nacional del Litoral) were kept in a controlled 124
environment (22ºC ± 2ºC; 14 h of light from 0600 h to 2000 h) with free access to pellet 125
laboratory chow (Nutrición Animal, Santa Fe, Argentina). The concentration of 126
phytoestrogens in the diet was not evaluated; however, because food intake of control 127
and BPA-treated rats was equivalent, we assumed that all animals were exposed to the 128
same levels of phytoestrogens (see Kass et al. [28] for more information regarding food 129
composition). To minimize the exposure to other endocrine-disrupting chemicals, rats 130
were housed in stainless steel cages with sterile pine wood shavings as bedding. Tap 131
water was supplied ad libitum in glass bottles with rubber stoppers.132
133
2.2 Experimental design.134
Females in proestrus were caged overnight with males of proven fertility. The day on 135
which sperm was found in the vagina was designated day 1 of gestation (GD1). On 136
GD9, which corresponds to the beginning of fetal organogenesis, pregnant rats were 137












weighed and randomly divided into three experimental groups: BPA-vehicle (0.001% 138
ethanol), BPA0.5 (0.5 g/kg-d, 99% purity, Sigma-Aldrich, Buenos Aires, Argentina) 139
and BPA50 (50 g/kg-d, Sigma-Aldrich), with 10-12 dams/group. BPA was 140
administered in the drinking water from GD9 to weaning (Fig. 1A). BPA solution was 141
prepared according to Kass et al. [28] and the dose was calculated on the basis of the 142
average weight of dams and water consumption during pregnancy and lactation. 143
144
After parturition, pups were weighed and sexed according to the anogenital distance; 145
litters of eight pups (preferably four males and four females) were left with lactating 146
mothers until weaning on postnatal day (PND) 21. One or two females from each litter 147
were evaluated at each time point. The remaining females and all males from each litter148
were assigned to other experiments. As an external index of female puberty onset, 149
vaginal opening was monitored daily starting on PND30. To evaluate the age-related 150
effects of perinatal exposure to BPA on the rat uterus, a group of females (n=10-16151
rats/group) were sacrificed in estrus on PND90 (young adults) and PND360 (adults) 152
(Fig. 1A). In addition, to investigate whether perinatal exposure to BPA modified the 153
response to a long-lasting treatment with E2, 12-month-old rats from the BPA-vehicle154
and BPA groups were ovariectomized (OVX) to avoid endogenous E2 variability, and 155
then treated with an E2 replacement therapy (n=9-14 rats/group) for 90 days (Fig. 1A). 156
Rats were implanted (sc) with silastic capsules (outer diameter: 3.18 mm, inner 157
diameter: 1.57 mm, 30 mm in length; Specialty Manufacturing, Midland, MI, USA) 158
filled with 1 mg E2/ml dissolved in sesame oil. A group of OVX rats without any 159
treatment (n=5) were implanted with sesame oil-filled capsules. The treatment with the 160
E2 implants produces constant blood levels of E2 that are equivalent to E2 circulating 161
levels during the rat estrous cycle [25]. This was verified by measuring E2 serum levels 162












(see section 2.10). This model is supposed to mimic the E2 replacement therapy via the 163
use of patches in menopausal women [25]. To ensure exposure to constant E2 levels, the 164
implants were changed every 30 days. After the treatment, the animals were sacrificed 165
(PND460-E2 groups). Two hours before the autopsy, each rat was injected (ip) with the 166
thymidine analog bromodeoxyuridine (BrdU; 60 mg/kg; Sigma-Aldrich).167
168
2.3 Complementary experiments.169
To evaluate whether the effects observed in the uterus of BPA-vehicle rats treated with 170
E2 (PND460-E2 groups) were due to the E2 treatment, the age of animals, or a 171
combination of both, we performed two complementary experiments (Fig. 1B): a) 172
PND90 rats (n=8-11) were OVX and treated with E2 for 3 months (as described in 173
section 2.2) and sacrificed at the end of the treatment (PND190-E2); b) Cycling female 174
rats (n=5) with no treatment were sacrificed on PND460. 175
176
2.4 Tissue sample collection. 177
The stage of the estrous cycle (proestrus, estrus, metestrus, or diestrus) of each 90- and 178
360-day-old rats was daily determined by vaginal smears [29] for at least 20 days prior 179
to sample collection. The rats were autopsied in estrus (evaluated by vaginal smears,180
positive lordosis behavior and uterus histology [30]) and uterine tissue was collected 181
and processed for different experimental purposes. For immunohistochemistry, one 182
uterine horn of each rat was fixed in 10% buffered formalin for 24 h at room 183
temperature and embedded in paraffin. For RNA extraction, the other uterine horn of 184
each rat was immediately frozen in liquid nitrogen and stored at -80ºC.185
186
2.5 Histology.187












Uterine samples embedded in paraffin were cut into 5-m sections, mounted on slides 188
coated with 3-aminopropyl triethoxysilane (Sigma-Aldrich) and stained with 189
hematoxylin and eosin for light microscopy (Olympus BH2, Tokyo, Japan). Uterine 190
glands were classified using the criteria described by Gunin et al. [31] and McLachlan 191
et al. [32]. To assess the incidence of epithelial or glandular abnormalities, the number 192
of rats with at least one abnormality of the chosen type was divided by the total number 193
of rats per group.194
195
2.5.1 Morphometry.196
The volume density of glands with squamous metaplasia was calculated by applying the 197
formula given by Weibel [33]: Vv = Pi/P, where Vv is the estimated volume density of 198
the object in study (glands with squamous metaplasia), Pi is the number of incident 199
points over these glands, and P is the number of incident points over all cells in the 200
studied population (stroma). To obtain the data for the point-counting procedure, a glass 201
disk with a squared grid of 0.8 mm x 0.8 mm was inserted into a focusing eyepiece. The 202
results were expressed as Vv x 1000.203
204
2.6 Immunohistochemistry.205
Uterine sections (5 μm in thickness) were deparaffinized and dehydrated in graded 206
ethanol. BrdU incorporation to detect cells in the S phase of the cell cycle was evaluated 207
as previously described [34]. Endogenous peroxidase activity and nonspecific binding 208
sites were blocked. Primary antibodies against the proliferation marker p63, steroid209
receptors, basal and luminal cytokeratins (CK), vimentin and smooth muscle -actin (-210
SMA) were incubated overnight at 4ºC (Table 1). The reactions were developed using a 211
streptavidin-biotin peroxidase method and diaminobenzidine (Sigma-Aldrich). Samples 212












were mounted with permanent mounting medium (Eukitt, Sigma-Aldrich). Each 213
immunohistochemical run included negative controls in which the primary antibody was 214
replaced by non-immune goat serum (Sigma-Aldrich). Negative controls for BrdU 215
immunodetection were samples from rats that did not receive BrdU.216
217
2.7 In situ detection of apoptosis.218
To evaluate apoptosis, sections were analyzed for in situ detection of cells with DNA 219
strand breaks using the terminal deoxynucleotidyl transferase-mediated deoxyuridine 220
triphosphate nick end labeling (TUNEL) technique (ApopTag; Intergen Co., Purchase, 221
NY, USA) as previously described [35]. 222
223
2.8 Image analysis.224
2.8.1 Cell proliferation and apoptosis.225
Immunostained tissue sections were evaluated using an Olympus BH2 microscope226
(Olympus Optical Co. Ltd, Tokyo, Japan), with a Dplan 100X objective (numerical 227
aperture = 1.25; Olympus). Incorporation of BrdU and apoptosis indices were 228
quantitatively analyzed in all tissue compartments of the uterus [35].229
230
2.8.2 Steroid receptors.231
The images of tissue sections were captured with a Dplan 20X objective (numerical 232
aperture, 0.65; Olympus). To measure the integrated optical density (IOD) of estrogen 233
receptor alpha and beta (ER and ER), and progesterone receptor (PR)234
immunostaining in the subepithelial stroma, images were analyzed using the Image Pro-235
Plus 4.1.0.1 system (Media Cybernetics, Silver Spring, MD, USA) [35]. At least 10 236
fields were recorded in each section, and three sections per rat were evaluated. The 237












subepithelial stromal compartment was delimited and the IODs were measured as 238
previously described [36]. Because the IOD is a dimensionless parameter, the results 239
were expressed as arbitrary units. 240
241
2.8.3 Vimentin and -SMA.242
The images were recorded as described above. The expression of vimentin was 243
evaluated in the periglandular stroma zone defined as the 10-m-wide area around the 244
glands (from the basement membrane towards the outer layers), and the relative area 245
occupied by vimentin-positive cells was determined [37]. -SMA expression was 246
measured as the proportion of the glandular perimeter occupied by cytoplasmic 247
projections of -SMA-positive cells (linear density) [38].248
249
2.8.4 p63 and cytokeratins.250
The expression profiles of CK8 (luminal CK) and CK34bE12 (basal CK) were 251
qualitatively evaluated on three uterine sections. The expression of p63 was evaluated in 252
glands with squamous metaplasia and expressed as percentage of p63-positive glandular 253
cells.254
255
2.9 Reverse transcription and real-time quantitative PCR analysis.256
2.9.1 RNA extraction and reverse transcription.257
Individual uterine horn samples were homogenized in TRIzol (Invitrogen, Carlsbad, 258
CA, USA), and RNA was prepared according to the manufacturer’s protocol. The 259
concentration of total RNA was assessed by A260, and the samples were stored at -80ºC 260
until needed. Equal quantities (1 g) of total RNA were reverse-transcribed into cDNA 261












with Moloney Murine Leukemia Virus reverse transcriptase (10 units; Promega, 262
Madison, WI, USA) as previously described [8]. 263
264
2.9.2 Real-time quantitative PCR.265
Each reverse-transcribed product was diluted with ribonuclease-free water to a final 266
volume of 60 l and further amplified in triplicate using the Real-Time Rotor-Gene Q 267
(Quiagen; Tecnolab; Buenos Aires, Argentina). The primer sequences used for 268
amplification of TAp63, Np63, IGF-I, IGF-IR and ribosomal subunit 18S 269
(housekeeping gene) cDNAs are described in Table S1 (Supplementary data). For270
cDNA amplification, 5 µl of cDNA was combined with HOT FIREPol EvaGreen qPCR 271
Mix Plus (Solis BioDyne; Biocientífica; Rosario, Argentina), and 10 pmol of each 272
primer (Invitrogen) in a final volume of 20 µl. After initial denaturation at 95ºC for 15 273
min, the reaction mixture was subjected to successive cycles of denaturation at 95ºC for 274
15 sec, annealing at 54ºC (ΔNp63), 55ºC (TAp63 and IGF-I), 57ºC (IGF-IR) and 60ºC 275
(18S) for 15 sec, extension at 72ºC for 15 sec and reading at 81ºC. Product purity was 276
confirmed by dissociation curves, and random samples were subjected to agarose gel 277
electrophoresis. Controls containing no template DNA were included in all assays, 278
yielding no consistent amplification. The relative expression levels of each target were 279
calculated based on the cycle threshold (CT) method [39]. The CT for each sample was 280
calculated using the Rotor-Gene Q – Pure Detection software (Version: 1.7, Quiagen; 281
Tecnolab). Accordingly, fold expression over control values was calculated for each 282
target by Relative Expression Software Tool V2.0.13 (REST; Quiagen; Tecnolab), 283
which is specifically designed to analyze data from real-time PCR. REST calculates the 284
relative expression ratio on the basis of the PCR efficiency and crossing point deviation 285
(∆ CP) of the investigated transcripts and on a newly developed randomization test. This 286












test estimates how many times the investigated transcript increases or decreases relative 287
to control, which is assigned a value of 1 [40]. No significant differences in CT values 288
were observed for 18S between the different experimental groups.289
290
2.10 Hormone assay291
Serum levels of E2 were measured in blood samples of PND460-E2 rats by 292
radioimmunoassay (RIA) after ethyl ether (Merck, Buenos Aires, Argentina) extraction 293
[38]. The antibody was provided by G. D. Niswender, and the labeled hormone was294
purchased from PerkinElmer Life and Analytical Sciences (Boston, MA, USA). Assay 295




All data are expressed as the mean ± SEM. The incidence of uterine lesions was 300
analyzed by the Fisher’s exact test. For all the other variables, univariate Analysis of 301
Covariance (ANCOVA) was applied to evaluate the sibling’s contribution as a possible 302
confounding factor in each time point evaluated (SPSS-PASW Statistics v. 18). In the 303
variables studied, the covariate did not influence the responses to the treatment. 304
Therefore, Kruskal-Wallis followed by Dunn’s post-test was used to establish 305




3.1. BPA general effects (results summarized in Table S2)310












As previously reported [28], exposure to BPA through drinking water did not produce 311
signs of embryotoxicity (i.e., all pregnant dams successfully delivered their pups, and 312
the number of live-born pups per litter was similar among groups, abnormal maternal or 313
nursing behavior, or changes in the dam body weight gain or water consumption). The 314
gestation length was unaltered since all dams delivered on GD23, and no gross 315
malformations were observed in pups at delivery or weaning. The litter sex ratio showed 316
no differences and was within the normal range (50% females and 50% males). Litter 317
survival and weight gained during lactation was unaltered. The onset of puberty in 318
female pups showed no significant differences between groups. All females on PND90319
exhibited regular estrous cycles (5 days). On PND360 and PND460, intermittent 320
extended periods of diestrus or extended periods of proestrus/estrus were occasionally 321
observed. However, the patterns of estrous cycles did not differ between BPA-treated 322
and BPA-vehicle group.323
324
3.2. Uterine evaluation in rats perinatally exposed to BPA325
3.2.1. Young adults (PND90)326
Uterine histology showed characteristic signs of estrus stage, such as: luminal dilation 327
and high percentage of apoptosis in the glands and luminal epithelium. No changes were 328
observed in the two BPA-treated groups compared with the BPA-vehicle group. In the 329
luminal epithelium, subepithelial stroma and muscular region, BrdU incorporation and 330
apoptotic indexes showed no differences between groups. In the glandular epithelium, a 331
significant decrease in proliferative activity was observed in animals exposed to BPA0.5 332
and BPA50 while apoptotic indexes were not modified (Fig. 2A-B). The vimentin and 333
α-SMA protein expression in the stromal cells, surrounding the glandular epithelium 334
was used to identify the fibroblastic and muscle immunophenotype of these cells. In the 335












BPA50-exposed group the percentage of glandular perimeter occupied by α-SMA-336
positive cells was significantly decreased (Fig. 2C). No differences were found in the 337
areas occupied by vimentin-positive cells (Fig. 2D). 338
339
3.2.2. Adults (PND360)340
Uterine histology showed characteristic signs of estrus stage. Morphological changes in 341
the uterine luminal epithelium such as regions with cuboidal epithelium instead of tall 342
columnar (Fig. 3B, double arrow) and abnormal cells (hypochromic nuclei and/or 343
atypical arrangement, clear cytoplasm) (Fig. 3B-C, arrow) were observed. The 344
incidence of these alterations was significantly higher in the BPA groups (BPA-vehicle345
12.5% vs. BPA0.5 58.3% and BPA50 60%; Table 2).346
347
In BPA-vehicle rats, different morphological types of uterine glands were observed: a) 348
normal glands (round, oval or elongated shape with simple cuboidal epithelium) (Fig. 349
3D, arrowhead), b) glands with squamous metaplasia (two or three layers of cells, 350
constituting a stratified epithelium) (Fig. 3D, arrow), c) glands with cellular anomalies351
(cylindrical epithelium, low nuclei/cytoplasm ratio, undefined cytoplasmic borders, or 352
cells with dispersed chromatin and atypical arrangement) (Fig. 3E), and d) cystic glands353
(usually large size, enlarged lumen and flat epithelium) (Fig. 3F). The incidence of 354
glands with cellular anomalies was higher in BPA50-treated rats than in BPA-vehicle 355
ones (BPA-vehicle 31.3% vs. BPA50 90%; Table 2).356
357
On PND360 the luminal and glandular epithelia were positive for ER and CK8 (a 358
marker of luminal cells), and negative for PR, basal CK (CK34βE12) and p63 (Fig. S1). 359
Glands with squamous cell metaplasia were p63-positive and expressed basal and 360












luminal CKs. CK34βE12 was evident in basal cells, whereas CK8 was restricted to 361
luminal cells. The expression of p63 was observed in more than one cellular layer of 362
squamous metaplasia, mainly in basal cells, which expressed ER. BPA exposure did 363
not affect the expression pattern of any of the molecules evaluated.364
365
3.3. Uterine response to estrogen in adult rats366
3.3.1. Morphological features of uterine tissue367
On PND460, the uterine tissue from OVX animals without any treatment exhibited368
signs of atrophy; the subepithelial stroma presented numerous cells with very narrow 369
cytoplasm and picnotic nuclei. The uterine glands had a narrow lumen, and an oval or 370
elongated shape with simple cuboidal epithelium, all features of atrophic glands. 371
PND460-E2 rats without BPA exposure showed glands with squamous metaplasia, 372
glands with cellular anomalies, cystic glands (abnormalities similar to those described in 373
BPA-vehicle cycling rats on PND360) and with the presence of glands with daughter 374
glands. These glands had various sizes and shapes –round, elongate, tortuous-, and 375
formed daughter glands inside the epithelium or inside the mother gland lumen or on the 376
outer surface of the mother gland, like budding glands (Fig.4). Interestingly, no 377
daughter glands were observed on PND360. 378
379
To find out whether the glands with daughter glands observed in the uteri of PND460-380
E2 rats were due to the E2 treatment, the age of animals, or both, complementary 381
experiments were performed. Uterine samples from PND190-E2 rats showed the 382
characteristic signs of estrogenic stimulation but without glandular abnormalities. On 383
the other hand, the uterine tissue from aged intact rats (PND460) showed glands with 384












daughter glands similar to those observed on PND460-E2 rats (PND460-E2 14.3% 385
versus PND460 25%).386
387
3.3.2. Glandular abnormalities in BPA-exposed rats388
In response to E2, the incidence of glandular abnormalities in the BPA-exposed groups 389
was higher. The incidence of cellular anomalies in glands was higher in the BPA50 390
group than in the BPA-vehicle group (BPA-vehicle 64.3% vs. BPA50 100%; Table 3). 391
The incidence of glands with daughter glands was higher in BPA0.5 rats than in BPA-392
vehicle ones (BPA-vehicle 14.3% vs. BPA0.5 66.7%; Table 3). The percentage of rats 393
that exhibited uterine glands with squamous metaplasia increased in all experimental 394
groups of PND460-E2 (Table 3), without reaching statistical significance. However, 395
when we recorded the multiplicity (evaluated as volume density) of glands with 396




OVX rats without any treatment showed E2 levels below the detection limit of the 401
assay. No significant differences in E2 serum levels were observed in PND460-E2 rats402
(BPA-vehicle 19.22 pg/ml ± 4.2; BPA0.5 19.3 pg/ml ± 9.8; BPA50 11.3 pg/ml ± 7.03).403
404
3.3.4. Steroid receptor expression and immunophenotype of uterine tissue 405
As mentioned before, ovarian steroid hormones regulate proliferation and differentiation 406
of the uterine epithelium through binding to their stromal receptors. Therefore, ERα, 407
ER and PR expression was evaluated in the subepithelial stroma in all PND460-E2408
groups. PR expression decreased in both BPA groups, while ERα expression was lower 409












in BPA50 rats (Fig. 6A and B). Regarding ER expression, no differences were 410
observed (Fig. 6). 411
412
The immunophenotype of uterine glands in PND460-E2 rats presented a pattern similar 413
to that found in PND360 rats (see Fig. S1). Moreover, BPA exposure did not affect the414
proliferative activity in PND460-E2 rats (Fig. S2).415
416
3.3.5. Expression of p63 and IGF-1 in uterine tissue417
RT-PCR results demonstrated that both N- and TA-p63 isoforms were expressed in 418
PND460-E2 rats (Fig. 7). TA-p63 was lower in BPA0.5 rats and higher in BPA50 ones419
(Fig. 7A). p63 immunostained cells/squamous metaplasia were significantly lower in 420
BPA0.5 (50.9%) than in BPA50 rats (64.4%) (Fig. 7C).421
422
To evaluate whether the IGF-I signaling pathway was implicated in the estrogen-423
induced effects on the glandular epithelium, RT-PCR assays were conducted in 424





The endometrium is one of the main targets for estrogenic chemicals and there are many 430
evidences about the adverse effect of xenoestrogens on the uterus [1, 8, 9, 41, 42]. In the 431
present study, we demonstrated that perinatal exposure to low doses of BPA, such as the 432
“safe dose” established by US EPA (equivalent to the high dose used here, BPA50), and 433
a dose 100 times lower than the safe dose (BPA0.5), can reprogram the uterus 434












development and consequently alter its differentiation and its response to an estrogenic 435
therapy later in life. These effects were demonstrated in female offspring born from 436
dams exposed to BPA by using oral administration during pregnancy and lactation. The 437
oral route is the most relevant for BPA exposure in the general population [26, 27].438
439
We showed that exposure to BPA during the perinatal period did not modify cell 440
apoptosis but reduced glandular cell proliferation on PND90 (young adults). In addition, 441
BPA50 exposure decreased -SMA expression in stromal cells surrounding the uterine 442
glandular epithelium, without changes in vimentin expression. Thus, the decrease in 443
glandular cell proliferation could be due to the altered tissue organization in the 444
surrounding stroma affecting the epithelial–stromal communication. We have 445
previously shown that females exposed to diethylstilbestrol (DES) exhibit uterine 446
glandular alteration similar to that described here [8]. In the same sense, Ramos et al. 447
[37] have shown that, in BPA-treated rats, the phenotype of periductal stromal cells in 448
the prostate and the glandular cell function are affected. Similar results were found in 449
the peritubular cells surrounding the seminiferous tubules of Caiman latirostris exposed 450
to pesticides [43]. Altered organization of the periglandular myoid cells could modify 451
signals involved in the control of cell proliferation and survival as well as the 452
coordinated relationship between proliferative activity and cell death necessary to 453
maintain tissue histoarchitecture and functions [43].454
455
On PND360 (adult rats), a few BPA-vehicle rats (12.5%) showed uterine tissue456
abnormalities, including morphological changes in the uterine luminal epithelium such 457
as epithelial regions with abnormal cells and cuboidal instead of tall columnar458
epithelium. In addition, BPA-vehicle rats showed different glandular lesions (cystic459












glands, glands with cellular anomalies, and glands with squamous metaplasia). As 460
previously demonstrated, these uterine changes occur during the normal female aging 461
process [8]. The aging process is associated with a decrease in cell proliferation and in 462
the expression of steroid receptors within different endometrial cell types [44]. Khalyfa 463
et al. [45] demonstrated age-related changes in the expression of estrogen target genes 464
in the mouse uterus, which suggests that the modified expression of genes may play a 465
role in reproductive senescence and explain the decline in reproductive function in old 466
animals. Although these abnormalities were histologically similar to those seen in our 467
aged BPA-vehicle animals, the incidence of luminal epithelium alterations was higher in 468
BPA-treated rats. Other authors have shown similar uterine epithelial abnormalities in 469
rodents exposed to BPA [24, 46], suggesting that these changes may be specific BPA-470
disruption patterns in the uterine epithelium. Moreover, BPA50-exposed rats showed a 471
higher incidence of glands with cellular anomalies. Our results are in agreement with 472
that reported by Newbold et al. [9, 47], who showed that neonatal treatment with BPA 473
induces pathologies in the adult rat uterus, including benign, premalignant, and 474
neoplastic changes.475
476
Rats on PND460-E2 showed levels of E2 about 11-19 pg/ml, and no differences were 477
found between BPA-vehicle and BPA-exposed rats. These values are coincident with478
serum physiological concentrations at the estrus stage in rats [48], showing that the E2 479
dose administered to the rats was in the range of low physiological values.480
481
Female offspring perinatally exposed to BPA and treated with E2 in the adulthood482
showed increased occurrence of glandular lesions. The BPA50 group showed higher483
incidence of glands with cellular anomalies and multiplicity of glands with squamous 484












metaplasia, whereas the BPA0.5 group showed higher incidence of glands with 485
daughter glands. We have previously demonstrated that rats perinatally exposed to DES486
show an altered response to E2 in the adulthood [8] similar to that of BPA-exposed rats. 487
It is interesting to note that BPA-vehicle rats treated with E2 (PND460-E2), but not the 488
PND190-E2 group, presented uterine glands with daughter glands and conglomerates of 489
glands. Since aging intact rats (PND460) exhibit those alterations in uterine glands,490
these results would indicate that glands with daughter glands appear in aged animals in491
the presence of endogenous or exogenous estrogens. Gunin et al. [31] suggested that 492
changes in the architecture of glands could be correlated with changes in mitosis 493
orientation. Results presented here demonstrated that the presence of glands with 494
daughter glands and conglomerates of glands are age-related. However, their higher 495
incidence in animals exposed to BPA suggests that perinatal exposure to xenoestrogens496
may increase the susceptibility to develop this type of lesions in the adulthood. It is 497
important to mention that these glandular lesions are considered preneoplastic 498
alterations [31]. 499
500
Stroma-epithelial interactions are critical for mediating the effects of hormones [11]. 501
We demonstrated that PR expression decreased in response to E2 in uterine stromal 502
cells in both BPA groups. Furthermore, we found decreased expression of ERα in503
BPA50 rats. Altered patterns of expression of hormonal receptors have been suggested 504
to play roles in the etiology of serious pathological alterations of the endometrium, 505
concerning mainly the glands and the stroma, including cystic endometrial hyperplasia 506
[49]. 507
508












The p63 transcription factor is transcribed from alternative splicing sites into two 509
isoforms either containing or lacking the N-terminal transactivation domain, TA or N,510
respectively. In adult tissues, p63 is expressed in stratified epithelia but not in single-511
layered epithelia, suggesting a role for p63 in the development and maintenance of 512
stratified epithelia [50]. Little is known about specific functions of TAp63 and Np63. 513
Koster et al. [50] demonstrated that TAp63 is the first p63 isoform expressed during 514
embryogenesis and that it is required for initiation of epithelial stratification. Our results 515
demonstrate that p63 expression was restricted to glands with squamous metaplasia. 516
Then, TAp63 was higher in the BPA50 group than in the BPA-vehicle one. This 517
increase in TAp63 would be mainly associated with the observed increase in the 518
multiplicity of glands with squamous metaplasia in BPA50 rats. Koster et al. [50]519
observed that ectopic expression of TAp63 in simple lung epithelium in vivo promotes 520
the induction of squamous metaplasia. Based on these results, we suggest that the 521
increased p63 expression in BPA50 rats may be associated with increased multiplicity 522
of squamous metaplasia. Unlike the BPA50 group, rats exposed to BPA0.5 presented 523
lower expression of TAp63 mRNA associated with lower expression of p63 in glands 524
with squamous metaplasia. 525
526
In rodents, E2 induces epithelial cell proliferation by acting through the ERα located in 527
the stroma, which stimulates the secretion of growth factors such as IGF-I, which acts in 528
a paracrine fashion on uterine epithelial IGF-I receptor (IGF-IR) [12]. It has been shown 529
that mice perinatally exposed to estrogens develop endometrial hyperplasia associated 530
with alterations in signaling pathways involving IGF-I and IGF-IR [51]. In response to 531
E2, rats exposed to BPA0.5 showed a decrease in mRNA expression of IGF-1 and IGF-532
IR. This suggests that the signaling pathway of IGF-I would not be associated with the 533












increased frequency of glands with daughter glands observed in BPA0.5 rats. More 534
studies are needed to better characterize this phenomenon. 535
536
The present results provide further evidence that BPA ingestion by pregnant-lactating537
dams induces numerous abnormalities in the uterine tissues of offspring when the 538
animals reach adulthood. Moreover, the adult uterine response to E2 was altered in the 539
offspring perinatally exposed to BPA. A comprehensive analysis is needed to evaluate 540
the potential hazards to humans and wildlife from exposure to BPA and other 541
xenoestrogens at doses considered as “safe” or from the daily intake level established as 542
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Figure 1. Schematic representation of the experimental protocol used to study the 
effects of perinatal (gestation + lactation) exposure to bisphenol A (BPA) and E2 
treatment on the uterus of young adult (PND90) and adult (PND360 or 460) females. A) 
Main experimental protocol. GD: gestational day, PND: postnatal day; E2: 17-
estradiol; OVX: ovariectomy. B) Complementary experiments, protocol used in non-
exposed females to study uterine tissue in PND190 rats treated with E2 versus older 
adult rats (PND460) without E2 treatment.
Figure 2. Effects of perinatal exposure to BPA on uterine tissue of young adult rats 
(PND90). Proliferative (A) and apoptotic (B) rate quantified by immunohistochemistry 
and TUNEL respectively, in the uterine glandular epithelium. Quantification of αSMA 
(C) and vimentin (D) immunostaining in the uterine periglandular stroma. αSMA 
staining is expressed as linear density, which is the proportion of the glandular 
perimeter occupied by cytoplasmic projections of αSMA-positive cells. Vimentin is 
expressed as the integrated optical density (IOD), which is a linear combination 
between the average of immunostaining intensity and the relative area occupied by 
positive cells. Each column represents the mean ± SEM (n>7 per group). *, P<0.05 vs. 
the BPA-vehicle group.
Figure 3. Effects of perinatal exposure to BPA on the uterine luminal and glandular 
epithelium of adult rats (PND360). (A) Representative photomicrographs showing 
normal thickened uterine epithelium at estrus of BPA-vehicle rats (double arrow). In 
animals exposed to BPA (B-C) we observed regions with reduced thickness of the 












epithelium (double arrow), hypochromic nuclei, clear cytoplasm and/or atypical cell 
arrangement (arrows). In adult rats, different types of uterine glands were observed: (D) 
glands with squamous metaplasia (arrow) and normal glands (arrowhead), (E) glands
with cellular anomalies and (F) cystic glands. Scale bar: 50 m.
Figure 4. Representative photomicrographs showing uterine gland abnormalities in 
BPA-vehicle rats treated with E2 (PND460-E2). The uterine glands show glands with 
daughter glands (A) and glands forming conglomerates (B). Scale bar: A 50 m and B 
75 m.
Figure 5. Quantification of glands with squamous metaplasia in the uterus of PND460-
E2 rats. Each column represents the mean ± SEM (n>8 per group) of the volume density 
(Vv) x1000. *, P<0.05 vs. the BPA-vehicle group.
Figure 6. Effects of perinatal BPA exposure on the immunohistochemical expression of 
steroid receptors in uterine tissue of PND460-E2 rats. (A) Photomicrographs showing 
detection of PR, ER, and ER in the subepithelial stroma of uterine sections. These 
images were obtained from sections without hematoxylin counterstaining. Scale bar: 50 
m. (B) Quantification of steroid receptor immunostaining evaluated as integrated 
optical density (IOD). Results are expressed as relative units. Each column represents 
the mean ± SEM (n>8 per group). *, P<0.05 vs. the BPA-vehicle group.
Figure 7. Effect of perinatal exposure to BPA on p63 expression in the uterus of 
PND460-E2 rats. (A-B) Relative Tap63 and ΔNp63 mRNA levels measured by real-
time RT-PCR. Samples were normalized to 18S expression and to control animals; a 












value of 1 was assigned to the control group (REST 2009 software). (C) 
Immunohistochemistry expression of p63 protein in glands with squamous metaplasia 
of BPA-vehicle and BPA-exposed animals. *, P<0.05 vs. the BPA-vehicle group. Scale 
bar: 50 m.
Figure 8. Effect of perinatal exposure to BPA on IGF-I and IGF-IR expression in the 
uterus of PND460-E2. Relative IGF-I and IGF-IR mRNA levels were measured by real-
time RT-PCR. Samples were normalized to 18S expression and to control animals; a 
value of 1 was assigned to the control group (REST 2009 software). *, P<0.05.
Supplemental Figure S1. Photomicrographs showing immunohistochemical detection 
of ER, PR, CK8, basal CK (CK34βE12) and p63 in the luminal epithelium and in the 
different types of glands in rats on PND360. Normal glands (black arrowhead), cystic 
glands (white arrowhead), glands with cellular anomalies (white arrow) and glands with 
squamous metaplasia (black arrow). Scale bar: 50 m. 
Supplemental Figure S2. Photomicrographs showing immunohistochemical detection 
of BrdU in uterine glands of PND460-E2 rats. BrdU incorporation of BPA-vehicle (A),
BPA0.5 (B), and BPA50 (C) rats. Scale bar: 50 m.












Table 1.Antibodies used for Immunohistochemistry
Primary Antibodies Dilution Supplier
Anti-PR (clone A0098) 1/500 Dako Corp. (Carpinteria, CA, USA)
Anti-ERα (clone 6F-11) 1/200 Novocastra, Newcastle upon Tyne, UK
Anti-p63 (clone 4A4) 1/100 Santa Cruz Biotechnology Inc. (Santa Cruz, 
CA, USA)
Anti-pan-CK basal (clone 34βE12) 1/100 Novocastra, Newcastle upon Tyne, UK
Anti-CK8 1/1600 The Binding Site Limited, (Birmingham, 
UK)
Anti-BrdU (clone 85-2C8) 1/100 Novocastra, Newcastle upon Tyne, UK
Anti-ERβ (clone EMRO2) 1/100 Novocastra, Newcastle upon Tyne, UK
Anti-Vimentin (clone V9) 1/50 Novocastra, Newcastle upon Tyne, UK
Anti-Smooth muscle -actin
(α-SMA clone αsm-1)
1/100 Novocastra, Newcastle upon Tyne, UK
Secondary Antibodies Dilution Supplier
Anti-mouse 1/80 Sigma (St. Louis, MO, USA)
Anti-goat 1/200 Sigma (St. Louis, MO, USA)
Anti-sheep 1/200 Sigma (St. Louis, MO, USA)












Table 2. Incidence of histologically diagnosed uterine abnormalities in adult rats 
(PND360) perinatally exposed to BPA 




2/16 (12.5%) 7/12 (58.3%)a 6/10 (60%)a
glands with squamous 
metaplasia
9/16 (56.3%) 10/12 (83.3%) 5/10 (50%)
glands with cellular 
anomalies
5/16 (31.3%) 7/12 (58.3%) 9/10 (90%)a
cystic glands 10/16 (62.5%) 8/12 (66.7%) 7/10 (70%)
Results are expressed as number of affected rats vs. total rats per group. a p<0.05 
compared with the BPA-vehicle group.












Table 3. Incidence of histologically diagnosed uterine abnormalities in adult rats
perinatally exposed to BPA and treated with E2 (PND460-E2 group) 
                                    Treatment
BPA-vehicle BPA0.5 BPA50 
luminal epithelium 
anomalies
2/14 (14.3%) 0/9 (0%) 3/9 (33.3%)
glands with cellular 
anomalies
9/14 (64.3%) 8/9 (88.9%) 9/9 (100%)a
glands with daughter 
glands
2/14 (14.3%) 6/9 (66.7%)a 3/9 (33.3%)
glands with squamous 
metaplasia
10/14 (71.4%) 9/9 (100%) 8/9 (88.88%)
cystic glands 9/14 (64.3%) 9/9 (100%) 8/9 (88.9%)
Results are expressed as number of affected rats vs. total rats per group a p<0.05 
compared with the BPA-vehicle group.
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Figure 8
